Costs and net health effects of contraceptive methods.

[1]  B. Law.  Barrier methods. , 1971, Medical gynaecology and sociology.

[2]  W. Mccormack,et al.  Acute Pelvic Inflammatory Disease: Characteristics of Patients with Gonococcal and Nongonococcal Infection and Evaluation of Their Response to Treatment with Aqueous Procaine Penicillin G and Spectinomycin Hydrochloride , 1977, Sexually transmitted diseases.

[3]  Joseph S. Pliskin,et al.  Utility Functions for Life Years and Health Status , 1980, Oper. Res..

[4]  S. Pauker,et al.  The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.

[5]  J. Ross,et al.  Voluntary sterilization: an international fact book. , 1985 .

[6]  B. McNeil,et al.  Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  J. Fraumeni,et al.  Epidemiology of uterine cervical cancer. , 1986, Journal of chronic diseases.

[8]  G. Torrance.  Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[9]  A. Washington,et al.  The economic cost of pelvic inflammatory disease. , 1986, JAMA.

[10]  J. Kendrick,et al.  Relative impact of smoking and oral contraceptive use on women in the US , 1987 .

[11]  D. Celentano,et al.  The role of contraceptive use in cervical cancer: the Maryland Cervical Cancer Case-Control Study. , 1987, American journal of epidemiology.

[12]  J. Kendrick,et al.  The relative impact of smoking and oral contraceptive use on women in the United States. , 1987, JAMA.

[13]  C. la Vecchia,et al.  Barrier methods of contraception and the risk of cervical neoplasia. , 1989, Contraception.

[14]  E. Jones,et al.  Contraceptive failure in the United States: revised estimates from the 1982 National Survey of Family Growth. , 1989, Family planning perspectives.

[15]  T. French,et al.  Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. , 1989, American journal of epidemiology.

[16]  V. Beral,et al.  Contraception and ectopic pregnancy risk. , 1990, American Journal of Obstetrics and Gynecology.

[17]  R. Redfield,et al.  Tracking the spread of the HIV infection epidemic among young adults in the United States: results of the first four years of screening among civilian applicants for U.S. military service. , 1990, Journal of acquired immune deficiency syndromes.

[18]  I. Sivin.  Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. , 1991, Obstetrics and gynecology.

[19]  S. Harlap,et al.  Preventing pregnancy protecting health: a new look at birth control choices in the United States. , 1991 .

[20]  Ectopic pregnancy--United States, 1988-1989. , 1992, MMWR. Morbidity and mortality weekly report.

[21]  G. Anderson,et al.  Tubal sterilization and risk of subsequent hospital admission for menstrual disorders. , 1992, American journal of obstetrics and gynecology.

[22]  B. Rosner,et al.  A quantitative assessment of oral contraceptive use and risk of ovarian cancer , 1992, Obstetrics and gynecology.

[23]  A. Lazzarin,et al.  Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. , 1993, Journal of acquired immune deficiency syndromes.

[24]  P. Hall.  The introduction of Cyclofem into national family planning programmes: experience from studies in Indonesia, Jamaica, Mexico, Thailand and Tunisia. Task Force on Research on Introduction and Transfer of Technologies for Fertility Regulation, Special Programme of Research, Development and Research Tr , 1994, Contraception.

[25]  World Health Organization Collaborative Study of Cardiov Contarception.  Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study , 1995, The Lancet.

[26]  T. Farley,et al.  Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. , 1995, Lancet.

[27]  J. Trussell,et al.  The economic value of contraception: a comparison of 15 methods. , 1995, American journal of public health.

[28]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[29]  M. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[30]  S. Sidney,et al.  Stroke in users of low-dose oral contraceptives. , 1996, The New England journal of medicine.

[31]  J. Trussell,et al.  "The Risk of Pregnancy after Tubal Sterilization: Findings from the U.S. Collaborative Review of Sterilization." , 1996 .

[32]  M C Weinstein,et al.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[33]  Julian Peto,et al.  Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.

[34]  M. C. Leske,et al.  Breast cancer and hormonal contraceptives: further results , 1996 .

[35]  J. Trussell,et al.  The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. , 1996, American journal of obstetrics and gynecology.

[36]  Milton C. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996 .

[37]  M C Weinstein,et al.  Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning. , 1996, Medical care.

[38]  J. Hughes,et al.  A prospective study of risk factors for symptomatic urinary tract infection in young women. , 1996, The New England journal of medicine.

[39]  D. Soper.  Pelvic Inflammatory Disease (PID) , 1996, Infectious diseases in obstetrics and gynecology.

[40]  Milton C. Weinstein,et al.  Recommendations for Reporting Cost-effectiveness Analyses , 1996 .

[41]  J. Shelton,et al.  Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives. , 1997, Contraception.

[42]  J. Trussell,et al.  Medical care cost savings from adolescent contraceptive use. , 1997, Family planning perspectives.

[43]  L. Koonin,et al.  Abortion surveillance--United States, 1993 and 1994. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[44]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[45]  A. Chandra,et al.  Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. , 1997, Vital and health statistics. Series 23, Data from the National Survey of Family Growth.

[46]  M. Marmot,et al.  Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study , 1997, The Lancet.

[47]  J. Trussell,et al.  The Risk of Ectopic Pregnancy after Tubal Sterilization. , 1997 .

[48]  S. Henshaw.  Unintended pregnancy in the United States. , 1998, Family planning perspectives.

[49]  K. Curtis,et al.  Visits to Emergency Departments for Gynecologic Disorders in the United States, 1992–1994 , 1998, Obstetrics and gynecology.

[50]  H. Guess,et al.  Safety and effectiveness of vasectomy. , 2000, Fertility and sterility.

[51]  J. Sobel,et al.  Urinary tract infection: self-reported incidence and associated costs. , 2000, Annals of epidemiology.

[52]  M. Kafrissen,et al.  Triphasic Norgestimate‐Ethinyl Estradiol for Treating Dysfunctional Uterine Bleeding , 2000, Obstetrics and gynecology.

[53]  M. Davidsen,et al.  Long-Term Survival and Causes of Death After Stroke , 2001, Stroke.

[54]  S. Curtin,et al.  Trends in pregnancy rates for the United States, 1976-97: an update. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[55]  M C Weinstein,et al.  The cost effectiveness of combination antiretroviral therapy for HIV disease. , 2001, The New England journal of medicine.

[56]  A. Arria,et al.  Maternal Mortality During Hospital Admission for Delivery: A Retrospective Analysis Using a State-Maintained Database , 2001, Anesthesia and analgesia.

[57]  A. Fisher,et al.  Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. , 2001, JAMA.

[58]  D. Apter,et al.  Efficacy, Cycle Control, and User Acceptability of a Novel Combined Contraceptive Vaginal Ring , 2002, Obstetrics and gynecology.

[59]  Oral contraceptives and the risk of breast cancer. , 2002, The New England journal of medicine.

[60]  E. Arias,et al.  United States life tables, 2000. , 2002, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[61]  Mandeep Singh,et al.  Scores for Post–Myocardial Infarction Risk Stratification in the Community , 2002, Circulation.

[62]  A. Fisher,et al.  Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. , 2002, Fertility and sterility.

[63]  A. Fisher,et al.  The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy. , 2004, Contraception.